Leonteq Securities AG’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,151
Closed -$67.5K 1294
2023
Q3
$67.5K Buy
1,151
+104
+10% +$6.5K ﹤0.01% 737
2023
Q2
$66K Buy
1,047
+90
+9% +$5.73K ﹤0.01% 774
2023
Q1
$60.2K Buy
+957
New +$57.1K ﹤0.01% 764
2022
Q3
Sell
-758
Closed -$54.8K 1346
2022
Q2
$54.8K Buy
758
+125
+20% +$9.31K ﹤0.01% 806
2022
Q1
$50.3K Buy
633
+78
+14% +$7.03K ﹤0.01% 860
2021
Q4
$56.2K Buy
555
+30
+6% +$2.99K ﹤0.01% 881
2021
Q3
$48.4K Buy
+525
New +$50.5K ﹤0.01% 856

Other funds holding USNA

Leonteq Securities AG's USNA Position: Q4 2023 in Review

Leonteq Securities AG sold out of Usana Health Sciences (USNA) in Q4 2023, closing a stake of 1,151 shares — an estimated $67.5K sold.

Leonteq Securities AG first reported a position in USNA in Q3 2021 and held it in 7 quarters. The position peaked at $67.5K in Q3 2023. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2023.

  • Leonteq Securities AG reported no remaining Usana Health Sciences position as of Q4 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 1,151 Usana Health Sciences shares in Q4 2023, an estimated $67.5K.
  • Leonteq Securities AG first reported a position in Usana Health Sciences in Q3 2021 and held it in 7 quarters.
  • Leonteq Securities AG's Usana Health Sciences position peaked at $67.5K in Q3 2023.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2023.

Based on Leonteq Securities AG's 13F filing for Q4 2023, filed 11 Mar 2026.